We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

Product News

Roche’s RTCA HT Instrument Adapts Real-Time Cell Analysis to a High-Throughput Format

RTCA HT Instrument´s design allows for integration with automated plate and liquid handling systems.
Product News

Oncodesign Offers World’s Most Comprehensive Collection of Patient-derived Colorectal Tumor Models

Collection of 53 models offers full range of characterization.
Product News

PRECOS and Argenta Extend Collaboration to Offer World Class Integrated Oncology Drug Discovery Services

The five-year extension of the alliance will allow both companies to offer unrivalled expertise in cancer research to their pharmaceutical clients.
Product News

Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial

Targeted antibody bavituximab to be evaluated in combination with pemetrexed and carboplatin for front-line non-small cell lung cancer.
Product News

Medivation and Astellas Announce Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen progression and radiographic progression.
Product News

Precision Therapeutics and Med BioGene Partner to Commercialize LungExpress Dx™

LungExpress Dx™ is a proprietary gene expression-based test to improve upon staging for identifying those patients with early-stage NSCLC.
Product News

Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47

L-DOS47 is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic, non-small cell lung cancer.
Product News

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.
Product News

Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Product News

Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Advertisement